Nocturnal Hypertension and Nocturia in African American Men
NCT ID: NCT03048734
Last Updated: 2020-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
19 participants
OBSERVATIONAL
2017-01-31
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We now went to pursue this correlation by designing a new NIH grant Proposal to determine whether replacing short acting with long acting drugs and dosing them at bed time rather than in the morning will:
A. Lower the systolic Blood pressure during sleep B. Improve Nocturia and results in better sleep quality. The results suggest that short acting hydrochlorothiazide may contribute to nocturia in some patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
NCT03374215
Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)
NCT01764711
Normal Pressure Hydrocephalus (NPH) Registry
NCT00233701
Anterior Pituitary Function in Patients With Hydrocephalus
NCT00149721
Volumetrics and Proteomics in Shunted Normal Pressure Hydrocephalus
NCT04785560
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Determine:
1. The feasibility of Southern California registry as an effective measure to recruit African American men to participate in a new research program.
2. If men will comply with the study procedures including Actigraphy and ambulatory blood pressure monitors.
3. The within subject coefficient of variation for repeated measures of nocturnal blood pressure by ambulatory blood pressure monitoring, vertical activity at night by Actigraphy monitors.
4. Whether the ambulatory Blood pressure itself affects the sleep pattern on Actigraphy.
5. Nocturnal systolic blood pressure and nocturnal vertical activity are higher in men with self-reported nocturia ≥2 at night than in men with no reported nocturia.
Purpose:
Obtain key pilot data to show feasibility and document the reproducibility of the proposed measurements.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group (1): Men with Nocturia ≥2.
No interventions assigned to this group
Group (2): Men with no nocturia (0-1).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 35 to 79 year-old
* Able to give informed consent
* Pass the home sleep study
* Willing to wear the wrist Actigraphy monitor for 9 days continuously.
* Willing to wear ambulatory blood pressure monitoring (ABPM) for 48 hours twice during the 9 days of the study period.
Exclusion Criteria
* Taking Prostate medication
* Symptoms of prostate disease or urinary urgency
* Sleep apnea
1. A neck circumference greater than 17 inches
2. Using Continuous Positive Airway Pressure (CPAP)
3. History of a diagnosis of Sleep Apnea
4. Apnea Hypopnea Index (AHI) \> 15 per hour
35 Years
79 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cedars-Sinai Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ronald Victor, MD
Role: PRINCIPAL_INVESTIGATOR
Cedars-Sinai Medical Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00046856
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.